company background image
IDXX logo

IDEXX Laboratories NasdaqGS:IDXX Stock Report

Last Price

US$571.68

Market Cap

US$47.8b

7D

3.0%

1Y

21.9%

Updated

28 Feb, 2024

Data

Company Financials +

IDEXX Laboratories, Inc.

NasdaqGS:IDXX Stock Report

Market Cap: US$47.8b

IDXX Stock Overview

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally.

IDXX fundamental analysis
Snowflake Score
Valuation0/6
Future Growth3/6
Past Performance6/6
Financial Health6/6
Dividends0/6

Rewards

Risk Analysis

No risks detected for IDXX from our risk checks.

IDEXX Laboratories, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for IDEXX Laboratories
Historical stock prices
Current Share PriceUS$571.68
52 Week HighUS$579.68
52 Week LowUS$372.50
Beta1.25
1 Month Change7.45%
3 Month Change22.73%
1 Year Change21.87%
3 Year Change14.79%
5 Year Change175.10%
Change since IPO60,375.27%

Recent News & Updates

Is It Too Late To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

Jan 30
Is It Too Late To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

Recent updates

Is It Too Late To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

Jan 30
Is It Too Late To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

IDEXX Laboratories: Valuation Rerating Doesn't Seem Justified

Jan 16

Here's Why IDEXX Laboratories (NASDAQ:IDXX) Has Caught The Eye Of Investors

Jan 15
Here's Why IDEXX Laboratories (NASDAQ:IDXX) Has Caught The Eye Of Investors

IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Shareholders Might Be Looking For Exit

Dec 31
IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Shareholders Might Be Looking For Exit

IDEXX Laboratories (NASDAQ:IDXX) Seems To Use Debt Rather Sparingly

Dec 15
IDEXX Laboratories (NASDAQ:IDXX) Seems To Use Debt Rather Sparingly

Why IDEXX Laboratories, Inc. (NASDAQ:IDXX) Could Be Worth Watching

Oct 26
Why IDEXX Laboratories, Inc. (NASDAQ:IDXX) Could Be Worth Watching

Here's Why We Think IDEXX Laboratories (NASDAQ:IDXX) Is Well Worth Watching

Oct 10
Here's Why We Think IDEXX Laboratories (NASDAQ:IDXX) Is Well Worth Watching

Is IDEXX Laboratories (NASDAQ:IDXX) Using Too Much Debt?

Sep 07
Is IDEXX Laboratories (NASDAQ:IDXX) Using Too Much Debt?

Is It Time To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

Jul 04
Is It Time To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

These 4 Measures Indicate That IDEXX Laboratories (NASDAQ:IDXX) Is Using Debt Reasonably Well

May 31
These 4 Measures Indicate That IDEXX Laboratories (NASDAQ:IDXX) Is Using Debt Reasonably Well

At US$484, Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth Looking At Closely?

Apr 05
At US$484, Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth Looking At Closely?

Here's Why IDEXX Laboratories (NASDAQ:IDXX) Can Manage Its Debt Responsibly

Feb 22
Here's Why IDEXX Laboratories (NASDAQ:IDXX) Can Manage Its Debt Responsibly

Why IDEXX Laboratories, Inc. (NASDAQ:IDXX) Could Be Worth Watching

Jan 05
Why IDEXX Laboratories, Inc. (NASDAQ:IDXX) Could Be Worth Watching

Is IDEXX Laboratories (NASDAQ:IDXX) Using Too Much Debt?

Nov 24
Is IDEXX Laboratories (NASDAQ:IDXX) Using Too Much Debt?

When Should You Buy IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

Sep 20
When Should You Buy IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

IDEXX Laboratories: Outstanding Business, But Valuation Is Key

Aug 15

These 4 Measures Indicate That IDEXX Laboratories (NASDAQ:IDXX) Is Using Debt Reasonably Well

Aug 15
These 4 Measures Indicate That IDEXX Laboratories (NASDAQ:IDXX) Is Using Debt Reasonably Well

IDEXX Laboratories Stock Is Very Expensive

Aug 08

IDEXX Laboratories Non-GAAP EPS of $1.58 misses by $0.05, revenue of $860.55M misses by $1.57M

Aug 02

Are IDEXX Laboratories, Inc. (NASDAQ:IDXX) Investors Paying Above The Intrinsic Value?

Jul 26
Are IDEXX Laboratories, Inc. (NASDAQ:IDXX) Investors Paying Above The Intrinsic Value?

Here's Why We Think IDEXX Laboratories (NASDAQ:IDXX) Might Deserve Your Attention Today

Jul 12
Here's Why We Think IDEXX Laboratories (NASDAQ:IDXX) Might Deserve Your Attention Today

Is It Time To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

Jun 16
Is It Time To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

IDEXX Laboratories: Great Business, But Still Overvalued

May 25

We Think IDEXX Laboratories (NASDAQ:IDXX) Can Manage Its Debt With Ease

May 06
We Think IDEXX Laboratories (NASDAQ:IDXX) Can Manage Its Debt With Ease

Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth US$474 Based On Its Intrinsic Value?

Apr 23
Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth US$474 Based On Its Intrinsic Value?

With EPS Growth And More, IDEXX Laboratories (NASDAQ:IDXX) Is Interesting

Apr 09
With EPS Growth And More, IDEXX Laboratories (NASDAQ:IDXX) Is Interesting

Is It Too Late To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

Mar 07
Is It Too Late To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

IDEXX Laboratories And Its Real Value

Feb 02

Does IDEXX Laboratories (NASDAQ:IDXX) Deserve A Spot On Your Watchlist?

Jan 06
Does IDEXX Laboratories (NASDAQ:IDXX) Deserve A Spot On Your Watchlist?

IDEXX: A Wonderful Business At An Unreasonably High Price

Nov 24

These 4 Measures Indicate That IDEXX Laboratories (NASDAQ:IDXX) Is Using Debt Safely

Oct 17
These 4 Measures Indicate That IDEXX Laboratories (NASDAQ:IDXX) Is Using Debt Safely

With EPS Growth And More, IDEXX Laboratories (NASDAQ:IDXX) Is Interesting

Oct 04
With EPS Growth And More, IDEXX Laboratories (NASDAQ:IDXX) Is Interesting

Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Potentially Undervalued?

Sep 08
Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Potentially Undervalued?

Shareholder Returns

IDXXUS Medical EquipmentUS Market
7D3.0%-0.03%1.8%
1Y21.9%12.6%25.6%

Return vs Industry: IDXX exceeded the US Medical Equipment industry which returned 12.6% over the past year.

Return vs Market: IDXX underperformed the US Market which returned 25.6% over the past year.

Price Volatility

Is IDXX's price volatile compared to industry and market?
IDXX volatility
IDXX Average Weekly Movement4.5%
Medical Equipment Industry Average Movement8.3%
Market Average Movement6.1%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.1%

Stable Share Price: IDXX has not had significant price volatility in the past 3 months.

Volatility Over Time: IDXX's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
198311,000Jay Mazelskyhttps://www.idexx.com

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community.

IDEXX Laboratories, Inc. Fundamentals Summary

How do IDEXX Laboratories's earnings and revenue compare to its market cap?
IDXX fundamental statistics
Market capUS$47.78b
Earnings (TTM)US$845.04m
Revenue (TTM)US$3.66b

56.2x

P/E Ratio

13.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IDXX income statement (TTM)
RevenueUS$3.66b
Cost of RevenueUS$1.47b
Gross ProfitUS$2.19b
Other ExpensesUS$1.34b
EarningsUS$845.04m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 02, 2024

Earnings per share (EPS)10.17
Gross Margin59.82%
Net Profit Margin23.08%
Debt/Equity Ratio63.9%

How did IDXX perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.